Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-24 @ 5:49 AM
Study NCT ID:
NCT00045968
Status:
UNKNOWN
Last Update Posted:
2022-05-18
First Post:
2002-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sponsor:
Northwest Biotherapeutics
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | oncology | View |
| None | neurology | View |
| None | glioma | View |
| None | brain tumor | View |
| None | brain cancer | View |
| None | glioblastoma multiforme | View |
| None | glioblastoma | View |
| None | newly diagnosed glioblastoma | View |
| None | immunotherapy | View |
| None | dendritic cells | View |
| None | immune therapy | View |
| None | GBM | View |
| None | Brain cancer, primary | View |
| None | tumor vaccine | View |
| None | grade IV astrocytoma | View |
| None | DCVax | View |
| None | Grade IV brain cancer | View |